INGEVITY CORPORATION (NGVT) Spending and interest coverage
- R&D / revenue · 12 months: Value 2.34%; Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 2.34% | Research and development expense / revenue. Period ending 2026-06-30. $27.20M ÷ $1.16B × 100 ≈ 2.34% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 27.20M USD | Research and Development Expense |
| Revenue | 1.16B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | (m) | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $27.20M | $1.16B | (m) | (m) | (m) | 2.34% | (m) | (m) | (m) |
| 2026-03-31 | $28.10M | $1.18B | (m) | (m) | (m) | 2.39% | (m) | (m) | (m) |
| 2025-12-31 | $28.40M | $1.17B | (m) | $418.70M | $78.30M | 2.43% | (m) | 5.35× | Reported |
| 2025-09-30 | $31.10M | $1.38B | (m) | (m) | (m) | 2.25% | (m) | (m) | (m) |
| 2025-06-30 | $29.50M | $1.32B | (m) | (m) | (m) | 2.23% | (m) | (m) | (m) |
| 2025-03-31 | $29.00M | $1.35B | (m) | (m) | (m) | 2.15% | (m) | (m) | (m) |
| 2024-12-31 | $28.10M | $1.41B | (m) | $369.00M | $97.80M | 2.00% | (m) | 3.77× | Reported |
| 2024-09-30 | $28.00M | $1.48B | (m) | $350.20M | (m) | 1.89% | (m) | (m) | (m) |
| 2024-06-30 | $29.10M | $1.55B | (m) | $350.40M | (m) | 1.88% | (m) | (m) | (m) |
| 2024-03-31 | $29.80M | $1.64B | (m) | $369.80M | (m) | 1.82% | (m) | (m) | (m) |
| 2023-12-31 | $31.80M | $1.69B | (m) | $396.80M | $93.30M | 1.88% | (m) | 4.25× | Reported |
| 2023-09-30 | $31.80M | $1.70B | (m) | $409.30M | (m) | 1.87% | (m) | (m) | (m) |
| 2023-06-30 | $31.60M | $1.74B | (m) | $437.10M | (m) | 1.82% | (m) | (m) | (m) |
| 2023-03-31 | $31.80M | $1.68B | (m) | $437.50M | (m) | 1.90% | (m) | (m) | (m) |
| 2022-12-31 | $30.30M | $1.67B | (m) | $452.60M | $61.80M | 1.82% | (m) | 7.32× | Reported |
| 2022-09-30 | $30.10M | $1.62B | (m) | $457.90M | (m) | 1.86% | (m) | (m) | (m) |
| 2022-06-30 | $29.30M | $1.52B | (m) | $439.20M | (m) | 1.93% | (m) | (m) | (m) |
| 2022-03-31 | $27.00M | $1.45B | (m) | $435.80M | (m) | 1.86% | (m) | (m) | (m) |
| 2021-12-31 | $26.30M | $1.39B | (m) | $422.20M | $51.70M | 1.89% | (m) | 8.17× | Reported |
| 2021-09-30 | $25.10M | $1.38B | (m) | $453.50M | (m) | 1.82% | (m) | (m) | (m) |
| 2021-06-30 | $23.50M | $1.34B | (m) | $461.60M | (m) | 1.76% | (m) | (m) | (m) |
| 2021-03-31 | $23.00M | $1.25B | (m) | $411.10M | (m) | 1.84% | (m) | (m) | (m) |
| 2020-12-31 | $22.60M | $1.22B | $8.40M | $397.90M | $47.10M | 1.86% | 0.69% | 8.45× | Reported |
| 2020-09-30 | $21.50M | $1.19B | (m) | $378.10M | (m) | 1.80% | (m) | (m) | (m) |
| 2020-06-30 | $21.20M | $1.22B | (m) | $364.50M | (m) | 1.73% | (m) | (m) | (m) |
| 2020-03-31 | $20.80M | $1.30B | (m) | $405.60M | (m) | 1.59% | (m) | (m) | (m) |
| 2019-12-31 | $19.70M | $1.29B | (m) | $396.90M | $54.60M | 1.52% | (m) | 7.27× | Reported |
| 2019-09-30 | $20.20M | $1.27B | (m) | $322.10M | (m) | 1.59% | (m) | (m) | (m) |
| 2019-06-30 | $20.90M | $1.22B | (m) | $298.80M | (m) | 1.71% | (m) | (m) | (m) |
| 2019-03-31 | $21.60M | $1.18B | (m) | $279.90M | (m) | 1.84% | (m) | (m) | (m) |
| 2018-12-31 | $21.50M | $1.13B | (m) | $263.50M | $33.20M | 1.90% | (m) | 7.94× | Reported |
| 2018-09-30 | $21.50M | (m) | (m) | $247.70M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | $20.70M | (m) | (m) | $234.40M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $19.70M | (m) | (m) | $218.00M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $19.80M | (m) | (m) | $202.30M | $18.10M | (m) | (m) | 11.18× | Reported |
| 2017-09-30 | $9.00M | (m) | (m) | $185.30M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $8.10M | (m) | (m) | $172.10M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $8.10M | (m) | (m) | $164.20M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $7.60M | (m) | (m) | $163.60M | $19.30M | (m) | (m) | 8.48× | Reported |
| 2016-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $6.90M | (m) | (m) | $166.30M | $20.10M | (m) | (m) | 8.27× | Reported |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $7.80M | (m) | (m) | $213.30M | $16.40M | (m) | (m) | 13.01× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| Perimeter Solutions, Inc. (PRM) | $4.593B | -17.21 | |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |
| CitroTech Inc. (CITR) | United States | $0.097B | -5.12 |
| Loop Industries, Inc. (LOOP) | $0.023B | -5.50 |